Signaturefd LLC Buys 107 Shares of STERIS plc (NYSE:STE)

Posted by on Apr 13th, 2023

Signaturefd LLC raised its stake in shares of STERIS plc (NYSE:STE – Get Rating) by 3.2% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 3,482 shares of the medical equipment provider’s stock after purchasing an additional 107 shares during the quarter. Signaturefd LLC’s holdings in STERIS were worth $643,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Sumitomo Mitsui Trust Holdings Inc. increased its holdings in shares of STERIS by 6.3% during the 3rd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 431,406 shares of the medical equipment provider’s stock worth $71,734,000 after purchasing an additional 25,585 shares during the period. Chevy Chase Trust Holdings LLC increased its holdings in shares of STERIS by 1.0% during the 3rd quarter. Chevy Chase Trust Holdings LLC now owns 61,070 shares of the medical equipment provider’s stock worth $10,155,000 after purchasing an additional 603 shares during the period. Westpac Banking Corp increased its stake in STERIS by 29.7% in the third quarter. Westpac Banking Corp now owns 8,837 shares of the medical equipment provider’s stock valued at $1,469,000 after acquiring an additional 2,021 shares during the period. Foundry Partners LLC increased its stake in STERIS by 34.8% in the third quarter. Foundry Partners LLC now owns 1,799 shares of the medical equipment provider’s stock valued at $299,000 after acquiring an additional 464 shares during the period. Finally, Barclays PLC increased its stake in STERIS by 51.9% in the third quarter. Barclays PLC now owns 104,968 shares of the medical equipment provider’s stock valued at $17,455,000 after acquiring an additional 35,847 shares during the period. Institutional investors own 92.35% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. Stephens reissued an “overweight” rating and issued a $220.00 target price on shares of STERIS in a research note on Thursday, February 9th. JMP Securities lowered their target price on shares of STERIS from $250.00 to $240.00 and set a “market outperform” rating on the stock in a research note on Wednesday, February 15th. StockNews.com assumed coverage on shares of STERIS in a research note on Thursday, March 16th. They issued a “buy” rating on the stock. TheStreet cut shares of STERIS from a “b-” rating to a “c+” rating in a research note on Wednesday, March 1st. Finally, Piper Sandler lowered their target price on shares of STERIS from $235.00 to $215.00 and set an “overweight” rating on the stock in a research note on Thursday, February 9th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $224.40.

STERIS Price Performance

Shares of STERIS stock opened at $193.51 on Thursday. The company has a current ratio of 2.48, a quick ratio of 1.61 and a debt-to-equity ratio of 0.50. The stock has a market capitalization of $19.21 billion, a price-to-earnings ratio of -667.25, a P/E/G ratio of 2.00 and a beta of 0.85. STERIS plc has a 1-year low of $159.21 and a 1-year high of $255.93. The firm’s 50-day moving average price is $190.23 and its two-hundred day moving average price is $184.35.

STERIS (NYSE:STE – Get Rating) last announced its earnings results on Wednesday, February 8th. The medical equipment provider reported $2.02 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.19 by ($0.17). STERIS had a positive return on equity of 12.86% and a negative net margin of 0.58%. The company had revenue of $1.22 billion for the quarter, compared to analyst estimates of $1.27 billion. During the same quarter in the previous year, the company posted $2.12 earnings per share. STERIS’s revenue for the quarter was up .8% on a year-over-year basis. On average, equities analysts predict that STERIS plc will post 8.05 earnings per share for the current fiscal year.

STERIS Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, March 23rd. Stockholders of record on Friday, February 24th were given a dividend of $0.47 per share. The ex-dividend date of this dividend was Thursday, February 23rd. This represents a $1.88 dividend on an annualized basis and a dividend yield of 0.97%. STERIS’s payout ratio is -648.25%.

About STERIS

(Get Rating)

STERIS Plc engages in the provision of healthcare and life science product and service solutions. It operates through the following segments: Healthcare, Life Sciences, Applied Sterilization Technologies, and Dental. The Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites.

See Also

Institutional Ownership by Quarter for STERIS (NYSE:STE)

Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.